Mara Dierssen
Affiliations: | Center for Genomic Regulation (CRG), Spain |
Google:
"Mara Dierssen"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Jesus Florez | research scientist | 1985-1989 | School of Medicine, University of Cantabria |
Children
Sign in to add trainee| Ricardo Gómez | post-doc | 2016-2017 | Center for Genomic Regulation (CRG) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Roper RJ, Goodlett CR, Martínez de Lagrán M, et al. (2020) Behavioral Phenotyping for Down Syndrome in Mice. Current Protocols in Mouse Biology. 10: e79 |
| Dierssen M, Fructuoso M, Martínez de Lagrán M, et al. (2020) Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions. Frontiers in Neuroscience. 14: 670 |
| Fructuoso M, Gu YC, Kassis N, et al. (2020) Ethanol-Induced Changes in Brain of Transgenic Mice Overexpressing DYRK1A. Molecular Neurobiology. 57: 3195-3205 |
| Alemany-González M, Gener T, Nebot P, et al. (2020) Prefrontal-hippocampal functional connectivity encodes recognition memory and is impaired in intellectual disability. Proceedings of the National Academy of Sciences of the United States of America. 117: 11788-11798 |
| Gu Y, Moroy G, Paul JL, et al. (2020) Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup Dietary Supplement: Role of Green Tea Catechins. International Journal of Molecular Sciences. 21 |
| Martínez Cué C, Dierssen M. (2020) Plasticity as a therapeutic target for improving cognition and behavior in Down syndrome. Progress in Brain Research. 251: 269-302 |
| Rueda N, Flórez J, Dierssen M, et al. (2020) Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome. Progress in Brain Research. 251: 245-268 |
| De Toma I, Ortega M, Aloy P, et al. (2019) DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment. Frontiers in Molecular Neuroscience. 12: 272 |
| Navarro-Romero A, Vázquez-Oliver A, Gomis-González M, et al. (2019) Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome. Neurobiology of Disease. 125: 92-106 |
| Faundez V, De Toma I, Bardoni B, et al. (2018) Translating molecular advances in Down syndrome and Fragile X syndrome into therapies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology |